Corcoran Nicholas
See remarks
Corcoran Nicholas has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Jul 15, 2026.
On the most recent filing, Corcoran Nicholas is listed as See remarks at TransMedics Group, Inc. Inside the rolling window, Corcoran Nicholas reported no open-market purchases and 1 open-market sale totaling $413K in TMDX.
Companies traded
Other insiders at TMDX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$413K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Corcoran Nicholas made?
Corcoran Nicholas has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company since 2026.
Which companies does Corcoran Nicholas trade?
Corcoran Nicholas has filed SEC Form 4 disclosures for 1 company, including TMDX.
When was Corcoran Nicholas's most recent SEC Form 4 filing?
Corcoran Nicholas's most recent SEC Form 4 filing on Tracefour is dated Jul 15, 2026.
What is Corcoran Nicholas's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Corcoran Nicholas is listed as See remarks.
What is Corcoran Nicholas's total buy and sell value in the current window?
Inside the rolling retention window, Corcoran Nicholas bought $0 and sold $413K based on SEC Form 4 filings.
What was Corcoran Nicholas's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 2,966 TMDX shares on 2026-03-02, worth $413K, per SEC Form 4 filings.